Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-036-0 | CAS number: 63225-53-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 Feb - 05 Mar 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted in 2002
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Federal Office of Public Health, the Swiss Agency for the Environment, Forests and Landscape and the Intercantonal Office for the Control of Medicines, Bern, Switzerland
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 2-[[(butylamino)carbonyl]oxy]ethyl acrylate
- EC Number:
- 264-036-0
- EC Name:
- 2-[[(butylamino)carbonyl]oxy]ethyl acrylate
- Cas Number:
- 63225-53-6
- Molecular formula:
- C10H17NO4
- IUPAC Name:
- 2-[[(butylamino)carbonyl]oxy]ethyl acrylate
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Jlbm
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Füllinsdorf, Switzerland
- Age at study initiation: 8 - 12 weeks old
- Weight at study initiation: 18.2 - 22.1 g
- Housing: in groups of 4 in Makrolon cages (type-3), softwood was used as bedding material
- Diet: pelleted standard Kliba 3433, mouse maintenance diet (Provimi Kliba AG, Kaiseraugst, Switzerland), ad libitum
- Water: community tap water, ad libitum
- Acclimation period: approx. 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 30-70
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 10, 25 and 50% (w/v)
- No. of animals per dose:
- range finding study: 2 females
main study: 4 females - Details on study design:
- RANGE FINDING TESTS:
To determine the highest non-irritant and technically applicable test substance concentration, a non-GLP pretest was performed in two animals with four concentrations (10%, 25% and 50% (w/v) and 100%).
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: 3H-methyl thymidine incorporation determined by ß-scintillation
- Criteria used to consider a positive response: A test substance is regarded as a sensitizer if two criteria are fulfilled. First, the exposure to at least one concentration of the test substance resulted in an incorporation of 3H-methyl thymidine at least 3-fold or greater than that recorded in control animals, as indicated by the Stimulation Index (SI). Second, the data must be compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION: The dorsal surface of both ears was topically treated (25 μL/ear) with the test substance concentration. The application was repeated on Days 2 and 3. Five days after the first topical application, each experimental mouse was administered 250 µl of 85.3 µCi/mL 3H-methyl thymidine (3H-TdR) by intravenous injection via the tail vein. Approximately five hours later, the draining lymph nodes were rapidly excised and pooled for each experimental group (8 nodes per group). Single cell suspensions of pooled lymph node cells were prepared in PBS by gentle mechanical disaggregation through stainless steel gauze (200 μm mesh size). Pooled lymph node cells were washed twice with PBS, resuspended in 5% trichloroacetic acid and incubated at approx. 4 °C for at least 18 h for precipitation of macromolecules. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The results of a reliability test with three concentrations of hexyl cinnamic aldehyde in acetone/olive oil (4:1 v/v) was performed not more than 6 months previously (Jan 2003) in CBA/CaOlaHsd mice using the same materials and essential procedures. The SI values calculated for the substance concentrations 5, 10 and 25% were 2.5, 3.7 and 9.7 respectively. An EC3 value of 7.08% was calculated.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 9.8
- Test group / Remarks:
- 10%
- Parameter:
- SI
- Value:
- 12.2
- Test group / Remarks:
- 25%
- Parameter:
- SI
- Value:
- 12.3
- Test group / Remarks:
- 50%
- Parameter:
- EC3
- Value:
- 1.56
- Remarks on result:
- other:
- Remarks:
- calculated based on ICCVAM method; see "Any other information on results incl. tables
Any other information on results incl. tables
Table1: Radioactivity counts (DPM) and Stimulation Index (SI).
Group |
TS1(%) |
DPM2/lymph node |
SI |
|
1 |
0 |
578 |
- |
|
2 |
10 |
5647 |
9.8 |
|
3 |
25 |
7068 |
12.2 |
|
4 |
50 |
7113 |
12.3 |
|
1TS = test substance (% w/v)
2DPM= Disintegrations per minute
Viability/Mortality: No deaths occurred during the study period.
Clinical signs: No clinical signs were observed in any animals of the control group. On the second application day, a slight to moderate swelling was observed at both dosing sites in all animals treated with test substance concentrations 10% and 25%, persisting for the remaining days. About 1.5 h after the first topical application, a slight swelling was observed at both dosing sites in all animals treated with test substance concentration 50%. On the second application day, the swelling increased to severe and a slight erythema was observed at both dosing sites. The signs persisted for the remaining days.
Body weights: The body weight of treated animals was within the range of the control.
EC3 value: The EC3 value was not calculated in the study report. However, it is possible to extrapolate the EC3 value using an equation provided by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) in which the two lowest test concentrations from the dose-response curve are used, provided the lowest SI value approaches the value of 3 and that a linear dose-response exists. The equation is as follows:
EC3 = 2 ^ [log2(c) + ((3 -d)/(b-d)) x (log2(a) - log2(c))], where a = dose concentration for next to lowest SI above 3; b = next to lowest SI above 3; c = dose concentration for lowest SI above 3; d = lowest SI above 3.
According to this extrapolation the EC3 value can be estimated as 1.56.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS Category 1A (H317) according to Regulation (EC) No 1272/2008
- Conclusions:
- CLP: Skin sens 1A, H317
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
